Business Context and Reporting Period
This Form 6-K filing by Scinai Immunotherapeutics Ltd. is dated November 13, 2025. The report serves to notify shareholders of an upcoming Annual General Meeting of Shareholders scheduled for December 22, 2025, at 11:00 a.m. Israel time in Tel Aviv, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing focuses solely on the administrative details of the upcoming shareholder meeting.
Guidance, Outlook, and Management Commentary
The filing includes no management commentary, financial guidance, or outlook. It details the following procedural items:
- Submission of the Notice and Proxy Statement (Exhibit 99.1) describing proposals to be voted upon.
- Submission of the Proxy Card (Exhibit 99.2) for American Depositary Share holders to vote remotely.
- Incorporation by reference into Registration Statements on Form S-8 and Form F-3.
Key Facts for Investor Verification
- Verify the specific proposals to be voted on in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the voting procedures and deadlines for the Annual General Meeting on December 22, 2025.
- Note that this filing contains no financial data; investors should refer to the most recent Form 20-F for financial metrics.